OverviewChartNewsTraderScreen

AETERNA ZENTARIS INC/  CA0079755017  /

Toronto
01/05/2024  21:57:22 Chg. +0.22 Volume Bid22:00:04 Ask22:00:04 High Low
2.82CAD +8.46% 8,609
Turnover: 24,445		 2.62Bid Size: 100 2.91Ask Size: 100 2.97 2.77
GlobeNewswire 01/05 Aeterna Zentaris Announces Effective Date of Share Consolidation
GlobeNewswire 29/04 Ceapro Inc. Reports 2023 Financial Results and Operational Highlights
GlobeNewswire 28/03 Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
GlobeNewswire 28/03 Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
GlobeNewswire 27/03 Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completio...
GlobeNewswire 12/03 Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
GlobeNewswire 12/03 Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
GlobeNewswire 26/02 Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders V...
GlobeNewswire 26/02 Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders V...
GlobeNewswire 23/02 Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceu...
GlobeNewswire 15/02 Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Sec...
GlobeNewswire 15/02 Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meetin...
GlobeNewswire 16/12/2023 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RAIN, BLBX, AEZS
GlobeNewswire 14/12/2023 Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Comp...
GlobeNewswire 09/11/2023 Aeterna Zentaris Reports Third Quarter 2023 Financial Results
GlobeNewswire 11/10/2023 Aeterna Zentaris to Participate at the Virtual Investor Ask the CEO Conference
GlobeNewswire 05/09/2023 Aeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire 29/03/2022 Aeterna Zentaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business O...
GlobeNewswire 21/03/2022 Aeterna Zentaris Provides Update on Ongoing Pivotal Phase 3 DETECT-Trial for the Diagnosis of Childh...
GlobeNewswire 10/03/2022 Aeterna Zentaris Announces Expansion of Research Program with Julius-Maximilians-University Wuerzbur...
GlobeNewswire 02/03/2022 Aeterna Zentaris Announces Notice of Allowance for U.S. Patent Covering AEZS-150 for the Potential T...
GlobeNewswire 07/02/2022 Aeterna Zentaris to Present at the 2022 BIO CEO & Investor Conference
GlobeNewswire 26/01/2022 Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rul...
GlobeNewswire 26/01/2022 Aeterna Zentaris Provides Business Outlook and Outlines Pipeline Priorities
GlobeNewswire 20/01/2022 Aeterna Zentaris to Present at the Virtual Investor 2022 Top Picks Conference